Zions Bancorporation’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-21
Closed -$303 923
2023
Q4
$303 Sell
21
-264
-93% -$3.59K ﹤0.01% 884
2023
Q3
$4.95K Buy
285
+58
+26% +$1.21K ﹤0.01% 726
2023
Q2
$4.72K Sell
227
-62
-21% -$1.35K ﹤0.01% 732
2023
Q1
$6.8K Sell
289
-89
-24% -$2.39K ﹤0.01% 702
2022
Q4
$10.6K Buy
378
+252
+200% +$6.44K ﹤0.01% 701
2022
Q3
$3K Sell
126
-165
-57% -$4.98K ﹤0.01% 841
2022
Q2
$10K Buy
291
+45
+18% +$1.58K ﹤0.01% 734
2022
Q1
$9K Buy
246
+48
+24% +$1.64K ﹤0.01% 841
2021
Q4
$7K Sell
198
-278
-58% -$9.05K ﹤0.01% 805
2021
Q3
$16K Sell
476
-137
-22% -$4.38K ﹤0.01% 645
2021
Q2
$19K Buy
+613
New +$20.2K ﹤0.01% 601

Other funds holding OGN

Zions Bancorporation's OGN Position: Q1 2024 in Review

Zions Bancorporation sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 21 shares — an estimated $303 sold.

Zions Bancorporation first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $19K in Q2 2021. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Zions Bancorporation reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
  • Zions Bancorporation sold 21 Organon & Co shares in Q1 2024, an estimated $303.
  • Zions Bancorporation first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
  • Zions Bancorporation's Organon & Co position peaked at $19K in Q2 2021.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Zions Bancorporation's 13F filing for Q1 2024, filed 14 May 2024.